Clinical epidemiology of gastric cancer

Singapore Medical Journal

Volumn 55, Issue 12, 2014, Pages 621-628

  Ang, Tiing Leong ^a   Fock, Kwong Ming ^a  

^a CHANGI GENERAL HOSPITAL   (Singapore)

Author keywords

Epidemiology; Gastric cancer; H. pylori

Indexed keywords

CHOLESTEROL; GLUCOSE; HEMOGLOBIN A; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; UVOMORULIN;

ACHLORHYDRIA; ATROPHY; CANCER MORTALITY; CANCER RISK; CHOLESTEROL BLOOD LEVEL; DIET; GENDER; GENE EXPRESSION; GENE MUTATION; GENETIC POLYMORPHISM; HELICOBACTER INFECTION; HYPERGLYCEMIA; HYPERLIPIDEMIA; INCIDENCE; LIFESTYLE; META ANALYSIS (TOPIC); METABOLIC SYNDROME X; MORTALITY; OBESITY; PREVALENCE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK FACTOR; SMOKING; STOMACH CANCER; COMPLICATION; FEMALE; GENETICS; HEALTH; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMAN; MALE; MICROBIOLOGY; STOMACH NEOPLASMS;

FEMALE; GLOBAL HEALTH; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; INCIDENCE; MALE; OBESITY; RISK FACTORS; STOMACH NEOPLASMS;

EID: 84916937411     PISSN: 00375675     EISSN: None     Source Type: Journal    
DOI: 10.11622/smedj.2014174     Document Type: Review

References (73)

1. Ferlay J, Shin HR, Bray F, et al. Estimates of worldwide burden of cancer in 2008: GLOBOSCAN 2008. Int J Cancer 2010; 127: 2893-917.
2. Ferlay J, Shin HR, Bray F, et al. GLOBOCAN 2008 v2. 0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 10 [Online]. Available: http://globocan. iarc. fr. Accessed June 3, 2014.
3. Fock KM, Ang TL. Epidemiology of Helicobacter pylori infection and gastric cancer in Asia. J Gastroenterol Hepatol 2010; 25: 479-86.
4. Wong BC, Lm SK, Ching CK, et al. Differential Helicobacter pylori infection rates in two contrasting gastric cancer risk regions of South China. China Gastric Cancer Study Group. J Gastroenterol Hepatol 1999; 14: 120-5.
5. Zhang DH, Zhou LY, Lin SR, et al. Recent changes in the prevalence of Helicobacter pylori infection among children and adults in high-or low-incidence regions of gastric cancer in China. Chin Med J (Engl) 2009; 122: 1759-63.
6. Aragonés N, Pérez-Gómez B, Pollán M, et al. The striking geographical pattern of gastric cancer mortality in Spain: environmental hypotheses revisited. BMC Cancer 2009; 9: 316.
7. Mezzanotte G, Cislaghi C, Decarli A, La Vecchia C. Cancer mortality in broad Italian geographical areas, 1975-1977. Tumori 1986; 72: 145-52.
8. Wong BC, Ching CK, Lam SK, et al. Differential north to south gastric cancer-duodenal ulcer gradient in China. China Ulcer Study Group. J Gastroenterol Hepatol 1998; 13: 1050-57.
9. Arnold M, Razum O, Coebergh JW. Cancer risk diversity in non-western migrants to Europe: An overview of the literature. Eur J Cancer 2010; 46: 2647-59.
10. Ronellenfitsch U, Kyobutungi C, Ott JJ, et al. Stomach cancer mortality in two large cohorts of migrants from the Former Soviet Union to Israel and Germany: are there implications for prevention? Eur J Gastroenterol Hepatol 2009; 21: 409-16.
11. Nguyen EV. Cancer in Asian American males: epidemiology, causes, prevention, and early detection. Asian Am Pac Isl J Health 2003; 10: 86-99.
12. Maskarinec G, Noh JJ. The effect of migration on cancer incidence among Japanese in Hawaii. Ethn Dis 2004; 14: 431-9.
13. Bertuccio P, Chatenoud L, Levi F, et al. Recent patterns in gastric cancer: a global overview. Int J Cancer 2009; 125: 666-73.
14. Matsuda A, Machii R. Trends in stomach cancer mortality rates in Japan, USA, UK, France and Korea based on the WHO mortality database. Jpn J Clin Oncol 2012; 42: 154.
15. Tanaka M, Ma E, Tanaka H, et al. Trends of stomach cancer mortality in Eastern Asia in 1950-2004: comparative study of Japan, Hong Kong and Singapore using age, period and cohort analysis. Int J Cancer 2012; 130: 930-6.
16. Anderson WF, Camargo MC, Fraumeni JF Jr, et al. Age-specific trends in incidence of noncardia gastric cancer in US adults. JAMA 2010; 303: 1723-8.
17. Bray F, Jemal A, Grey N, Ferlay J, Forman D. Global cancer transitions according to the Human Development Index (2008-2030): a population-based study. Lancet Oncol 2012; 13: 790-801.
18. Devesa SS, Blot WJ, Fraumeni JF Jr. Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer 1998; 83: 2049-53.
19. Botterweck AA, Schouten LJ, Volovics A, Dorant E, van Den Brandt PA. Trends in incidence of adenocarcinoma of the oesophagus and gastric cardia in ten European countries. Int J Epidemiol 2000; 29: 645-54.
20. de Martel C, Forman D, Plummer M. Gastric cancer: epidemiology and risk factors. Gastroenterol Clin North Am 2013; 42: 219-40.
21. Lauren P. The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. An attempt at a histo-clinical classification. Acta Pathol Microbiol Scand 1965; 64: 31-49.
22. Vauhkonen M, Vauhkonen H, Sipponen P. Pathology and molecular biology of gastric cancer. Best Pract Res Clin Gastroenterol 2006; 20: 651-74.
23. Laurén PA, Nevalainen TJ. Epidemiology of intestinal and diffuse types of gastric carcinoma. A time-trend study in Finland with comparison between studies from high-and low-risk areas. Cancer 1993; 71: 2926-33.
24. Ikeda Y, Mori M, Kamakura T, et al. Improvements in diagnosis have changed the incidence of histological types in advanced gastric cancer. Br J Cancer 1995; 72: 424-6.
25. Yu J, Zhao Q. The demographic characteristics of histological types of gastric cancer with gender, age, and tumor location. J Gastrointest Cancer 2009; 40: 98-100.
26. Popiela T, Kulig J, Kołodziejczyk P, Sierzega M. Changing patterns of gastric carcinoma over the past two decades in a single institution: clinicopathological findings in 1557 patients. Scand J Gastroenterol 2002; 37: 561-7.
27. Henson DE, Dittus C, Younes M, Nguyen H, Albores-Saavedra J. Differential trends in the intestinal and diffuse types of gastric carcinoma in the United States, 1973-2000: increase in the signet ring cell type. Arch Pathol Lab Med 2004; 128: 765-70.
28. Lundegårdh G, Lindgren A, Rohul A, et al. Intestinal and diffuse types of gastric cancer: secular trends in Sweden since 1951. Br J Cancer 1991; 64: 1182-6.
29. Kaneko S, Yoshimura T. Time trend analysis of gastric cancer incidence in Japan by histological types, 1975-1989. Br J Cancer 2001; 84: 400-5.
30. Helicobacter and Cancer Collaborative Group. Gastric cancer and Helicobacter pylori: a combined analysis of 12 case control studies nested within prospective cohorts. Gut 2001; 49: 347-53.
31. Graham DY, Lu H, Yamaoka Y. African, Asian or Indian enigma, the East Asian Helicobacter pylori: facts or medical myths. J Dig Dis 2009; 10: 77-84.
32. Fock KM, Talley N, Moayyedi P, et al. Asia-Pacific consensus guidelines on gastric cancer prevention. J Gastroenterol Hepatol 2008; 23: 351-65.
33. Mera R, Fontham ET, Bravo LE, et al. Long term follow up of patients treated for Helicobacter pylori infection. Gut 2005; 54: 1536-40.
34. Leung WK, Lin SR, Ching JY, et al. Factors predicting progression of gastric intestinal metaplasia: results of a randomized trial on Helicobacter pylori eradication. Gut 2004; 53: 1244-9.
35. Lee YC, Chen TH, Chiu HM, et al. The benefit of mass eradication of Helicobacter pylori infection: a community-based study of gastric cancer prevention. Gut 2013; 62: 676-82.
36. Rokkas T, Pistiolas D, Sechopoulos P, Robotis I, Margantinis G. The long-term impact of Helicobacter pylori eradication on gastric histology: a systematic review and meta-analysis. Helicobacter 2007; 12 Suppl 2: 32-8.
37. Wang J, Xu L, Shi R, et al. Gastric atrophy and intestinal metaplasia before and after Helicobacter pylori eradication: a meta-analysis. Digestion 2011; 83: 253-60.
38. Uemura N, Mukai T, Okamoto S, et al. Effect of Helicobacter pylori eradication on subsequent development of cancer after endoscopic resection of early gastric cancer. Cancer Epidemiol Biomarkers Prev 1997; 6: 639-42.
39. Uemura N, Okamoto S, Yamamoto S, et al. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 2001; 345: 784-9.
40. You WC, Brown LM, Zhang L, et al. Randomized double-blind factorial trial of three treatments to reduce the prevalence of precancerous gastric lesions. J Natl Cancer Inst 2006; 98: 974-83.
41. Zhou LY, Lin SR, Ding SG, et al. The changing trends of the incidence of gastric cancer after Helicobacter pylori eradication in Shandong area. Chin J Dig Dis 2005; 6: 114-5.
42. Wong BC, Lam SK, Wong WM, et al. Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial. JAMA 2004; 291: 187-94.
43. Saito D, Boku N, Fujioka T, et al. Impact of H. pylori eradication on gastric cancer prevention: endoscopic results of the Japanese Intervention Trial (JITHP-Study). A Randomized Multi-Center Trial. Gastroenterology 2005; 128 Suppl 2: A4.
44. Kato M, Asaka M. Eradication of Helicobacter pylori for the incidence of metachronous gastric cancer after endoscopic resection. J Gastroenterol Hepatol 2007; 22: A64.
45. Sato T, Fukuyama T, Suzuki T, et al. Studies of causation of gastric cancer 2. The relation between gastric cancer mortality rate and salted food intake in several places in Japan. Bull Inst Public Health 1959; 8: 187-98.
46. Wang XQ, Terry PD, Yan H. Review of salt consumption and stomach cancer risk: epidemiological and biological evidence. World J Gastroenterol 2009; 15: 2204-13.
47. Joossens JV, Hill MJ, Elliott P, et al. Dietary salt, nitrate and stomach cancer mortality in 24 countries. European Cancer Prevention (ECP) and the INTERSALT Cooperative Research Group. Int J Epidemiol 1996; 25: 494-504.
48. D'Elia L, Rossi G, Ippolito R, Cappuccio FP, Strazzullo P. Habitual salt intake and risk of gastric cancer: a meta-analysis of prospective studies. Clin Nutr 2012; 31: 489-98.
49. Ren JS, Kamangar F, Forman D, Islami F. Pickled food and risk of gastric cancer-a systematic review and meta-analysis of English and Chinese literature. Cancer Epidemiol Biomarkers Prev 2012; 21: 905-15.
50. Lunet N, Lacerda-Vieira A, Barros H. Fruit and vegetables consumption and gastric cancer: a systematic review and meta-analysis of cohort studies. Nutr Cancer 2005; 53: 1-10.
51. Bertuccio P, Rosato V, Andreano A, et al. Dietary patterns and gastric cancer risk: a systematic review and meta-analysis. Ann Oncol 2013; 24: 1450-8.
52. Boehm K, Borrelli F, Ernst E, et al. Green tea (Camellia sinensis) for the prevention of cancer. Cochrane Database Syst Rev 2009; 3: CD005004.
53. Sasazuki S, Tamakoshi A, Matsuo K, et al. Green tea consumption and gastric cancer risk: an evaluation based on a systematic review of epidemiologic evidence among the Japanese population. Jpn J Clin Oncol 2012; 42: 335-46.
54. Ladeiras-Lopes R, Pereira AK, Nogueira A, et al. Smoking and gastric cancer: systematic review and meta-analysis of cohort studies. Cancer Causes Control 2008; 19: 689-701.
55. Shimazu T, Tsuji I, Inoue M, et al. Alcohol drinking and gastric cancer risk: an evaluation based on a systematic review of epidemiologic evidence among the Japanese population. Jpn J Clin Oncol 2008; 38: 8-25.
56. Asano K, Kubo M, Yonemoto K, et al. Impact of serum total cholesterol on the incidence of gastric cancer in a population-based prospective study: the Hisayama study. Int J Cancer 2008; 122: 909-14.
57. Stemmermann GN, Chyou PH, Kagan A, Nomura AM, Yano K. Serum cholesterol and mortality among Japanese-American men. The Honolulu (Hawaii) Heart Program. Arch Intern Med 1991; 151: 969-72.
58. Eichholzer M, Stähelin HB, Gutzwiller F, Lüdin E, Bernasconi F. Association of low plasma cholesterol with mortality for cancer at various sites in men: 17-y follow-up of the prospective Basel study. Am J Clin Nutr 2000; 71: 569-74.
59. Iso H, Ikeda A, Inoue M, Sato S, Tsugane S. Serum cholesterol levels in relation to the incidence of cancer: the JPHC study cohorts. Int J Cancer 2009; 125: 2679-86.
60. Hu J, La Vecchia C, de Groh M, et al. Dietary cholesterol intake and cancer. Ann Oncol 2012; 23: 491-500.
61. Jung MK, Jeon SW, Cho CM, et al. Hyperglycaemia, hypercholesterolemia and the risk for developing gastric dysplasia. Dig Liver Dis 2008; 40: 361-5.
62. Ikeda F, Doi Y, Yonemoto K, et al. Hyperglycemia increases risk of gastric cancer posed by Helicobacter pylori infection: a population-based cohort study. Gastroenterology 2009; 136: 1234-41.
63. Kim HY. Metabolic syndrome is associated with gastric dysplasia. Eur J Gastroenterol Hepatol 2011; 23: 871-5.
64. Wu XD, Zeng K, Xue FQ, Chen JH, Chen YQ. Statins are associated with reduced risk of gastric cancer: a meta-analysis. Eur J Clin Pharmacol 2013; 69: 1855-60.
65. Yang P, Zhou Y, Chen B, et al. Overweight, obesity and gastric cancer risk: results from a meta-analysis of cohort studies. Eur J Cancer 2009; 45: 2867-73.
66. Sjodahl K, Jia C, Vatten L, et al. Body mass and physical activity and risk of gastric cancer in a population-based cohort study in Norway. Cancer Epidemiol Biomarkers Prev 2008; 17: 135-40.
67. Kuriyama S, Tsubono Y, Hozawa A, et al. Obesity and risk of cancer in Japan. Int J Cancer 2005; 113: 148-57.
68. El-Omar EM, Oien K, Murray LS, et al. Increased prevalence of precancerous changes in relatives of gastric cancer patients: critical role of H. pylori. Gastroenterology 2000; 118: 22-30.
69. Brenner H, Arndt V, Stürmer T, et al. Individual and joint contribution of family history and Helicobacter pylori infection to the risk of gastric carcinoma. Cancer 2000; 88: 274-9.
70. Seevaratnam R, Coburn N, Cardoso R, et al. A systematic review of the indications for genetic testing and prophylactic gastrectomy among patients with hereditary diffuse gastric cancer. Gastric Cancer 2012; 15 Suppl 1: S153-63.
71. El-Omar EM, Carrington M, Chow WH, et al. Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature 2000; 404: 398-402.
72. Persson C, Canedo P, Machado JC, El-Omar EM, Forman D. Polymorphisms in inflammatory response genes and their association with gastric cancer: A HuGE systematic review and meta-analyses. Am J Epidemiol 2011; 173: 259-70.
73. Lei Z, Tan IB, Das K, et al. Identification of molecular subtypes of gastric cancer with different responses to PI3-kinase inhibitors and 5-fluorouracil. Gastroenterology 2013; 145: 554-65.